MY120650A - Method and composition for ameliorating the adverse effects of aging. - Google Patents
Method and composition for ameliorating the adverse effects of aging.Info
- Publication number
- MY120650A MY120650A MYPI9100865A MY120650A MY 120650 A MY120650 A MY 120650A MY PI9100865 A MYPI9100865 A MY PI9100865A MY 120650 A MY120650 A MY 120650A
- Authority
- MY
- Malaysia
- Prior art keywords
- cells
- aging
- adverse effects
- kinetin
- methods
- Prior art date
Links
Abstract
6-(SUBSTITUTED AMINO) PURINE CYTOKININS, INCLUDING KINETIN, HAVE BEEN DISCOVERED TO AMELIORATE THE ADVERSE EFFECTS OF AGING ON MAMMALIAN CELLS, BY SLOWING OR REVERSING THE MORPHOLOGICAL CHANGES THAT NORMALLY ACCOMPANY AGING OF SUCH CELLS, WITHOUT SIGNIFICANTLY INCREASING THE GROWTH RATE OR TOTAL PROLIFERATIVE CAPACITY OF SUCH CELLS. THUS, METHODS ARE PROVIDED FOR COUNTERING THE ADVERSE EFFECTS OF AGING ON CELLS IN CULTURE AND IN VIVO WHICH COMPRISE ADMINISTERING TO SAID CELLS AN ADVERSE-AGE-EFFECT-AMELIORATIVE AMOUNT OF KINETIN OR ANOTHER 6-(SUBSTITUTED AMINO) PURINE CYTOKININ. COMPOSITIONS FOR CARRYING OUT THE METHODS ARE ALSO PROVIDED. AMONG THE PREFERRED APPLICATIONS OF THE INVENTION ARE THE PRESERVATION TO HUMAN SKIN OF KINETIN-CONTAINING LOTIONS, OINTMENTS OR CREAMS, THE HEALTH AND YOUTHFUL APPEARANCE OF SKIN.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI9100865 MY120650A (en) | 1991-05-22 | 1991-05-22 | Method and composition for ameliorating the adverse effects of aging. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI9100865 MY120650A (en) | 1991-05-22 | 1991-05-22 | Method and composition for ameliorating the adverse effects of aging. |
Publications (1)
Publication Number | Publication Date |
---|---|
MY120650A true MY120650A (en) | 2005-11-30 |
Family
ID=47257120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI9100865 MY120650A (en) | 1991-05-22 | 1991-05-22 | Method and composition for ameliorating the adverse effects of aging. |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY120650A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853386A (en) * | 1985-08-17 | 1989-08-01 | Boehringer Mannheim Gmbh | N6 -disubstituted purine derivatives, and pharmaceutical compositions containing them, useful for treating allergic diseases, bronchospastic and bronchoconstrictory conditions |
-
1991
- 1991-05-22 MY MYPI9100865 patent/MY120650A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853386A (en) * | 1985-08-17 | 1989-08-01 | Boehringer Mannheim Gmbh | N6 -disubstituted purine derivatives, and pharmaceutical compositions containing them, useful for treating allergic diseases, bronchospastic and bronchoconstrictory conditions |
Non-Patent Citations (1)
Title |
---|
THE MERCK INDEX, 9TH ED. PUB. 1976 PAGE 696, PARAGRAPH 5159. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture | |
Werner et al. | Human macrophages degrade tryptophan upon induction by interferon-gamma | |
IL110091A0 (en) | Imidazo [4,5-c] pyridin-4-amines and pharmaceutical compositions containing them | |
MX9709859A (en) | C-4' modified adenosine kinase inhibitors. | |
AP1411A (en) | Pyrrolo[2,3d] pyrimidine compositions and their use. | |
ES2102196T3 (en) | PERIPHERIALIZATION OF HEMATOPOYETIC PLURIPOTENTIAL CELLS. | |
EP1572961A4 (en) | Actriib fusion polypeptides and uses therefor | |
PT1053256E (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
HU9302496D0 (en) | Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds | |
MY103388A (en) | Azithromycin and derivatives as antiprotozoal agents | |
NZ223549A (en) | Macromolecular antitumour compositions containing platinum | |
ATE79720T1 (en) | METHODS OF PRESERVING TRANSPLANTABLE EPITHELIAL TISSUES CULTURED IN VITRO. | |
FI904604A0 (en) | PYRIMIDIN-4,6-DICARBOXYLSYRAAMIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DERAS ANVAENDNING SAMT PAO DESSA FOERENINGAR BASERADE CEEKEMEDEL. | |
CA2108369A1 (en) | Method and composition for ameliorating the adverse effects of aging | |
UA29466C2 (en) | Pharmaceutical composition with antitumour activity | |
EP0610286A4 (en) | Recombinant immunotoxins. | |
CA2151826A1 (en) | Pharmaceutical compositions for prevention and treatment of cancerous diseases and process for their preparation | |
MY120650A (en) | Method and composition for ameliorating the adverse effects of aging. | |
ES8301244A1 (en) | Sisomicin derivatives, process for their preparation and their use as pharmaceutical compositions. | |
GR3026154T3 (en) | Vitamin D3-analogs. | |
AU5312586A (en) | Composition and method for treatment of tumors with UDPG | |
CA2107896A1 (en) | Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins | |
SI1140149T1 (en) | Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment | |
ES2018726A6 (en) | Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof. | |
IL97801A0 (en) | Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same |